Pharmaceutical Research Associates Inc
Recherche - Victoria

Conducting an ADME study early in the clinical development program- generally before or in parallel with Phase IIa- is prudent since the outcome may generate the need for additional toxicology studies.Strategic Solutions Division: Capabilities & ExpertiseSeptember 1, 2014We deliver clinical development services you need through customized Embedded SolutionsTM designed to manage large and midsize biopharmaceutical companies' pipeline portfolios more efficiently and with greater flexibility and control.EventsWORLD DRUG SAFETY CONGRESSEUSeptember 10Prepare for the future drug safety landscape at the 7th annual World Drug Safety Congress Europe. The Fight Against Alzheimer's DiseaseSeptember 8, 2014US prevalence of Alzheimer's Disease is currently at 5 million sufferers and is set to triple by 2050.Engaging Clinical Trial Sites: The Role of the Clinical Trial LiaisonSeptember 1, 2014The ability to engage customers is a primary driver of business success because fully engaged customers tend to purchase more and are overall more profitable than those who are less engaged (Dasu & Chase, 2013).Human ADME and Studies with Radiolabeled Compounds: Phase IIIaSeptember 1, 2014Radiolabeled medication is widely used in the assessment of human ADME and also increasingly in assessing absolute bioavailability (BA).